Panacea
PrivateLast Round
Series B
Jan 16, 2024
Est. Valuation
$105.26M
Total Funding Raised
$24.5M
Company Overview
Panacea operates in FinTech. Its latest recorded funding round was a Series B round in January 2024.
Panacea is a healthcare technology company that provides AI-native FDA regulatory services by pairing expert consultants with an AI platform to accelerate the approval process for biotech and medtech companies.
Sector
FinTech
Verticals
Digital Banking, Lending & Credit, Personal Finance
Business Model
B2C
Customer Profile
Payment Processing Fee, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Panacea Comparables
Compare Panacea with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Doc2Doc Lending | 83% | |
| Fifth Third Bancorp | 80% | |
| KeyBank | 79% |
For institutional investors. Book with your work email.
Panacea Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Panacea Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Valar Ventures | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 16, 2024
$25M round led by Valar Ventures
For institutional investors. Book with your work email.
Panacea Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Panacea's valuation, stock price, and market status.
Is Panacea a public or private company?
Panacea is a private company.
What is the current stock price of Panacea?
Panacea is a private company, so its shares have no public market price. Caplight tracks Panacea's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Panacea worth (valuation)?
Panacea's valuation is estimated at $105.3M based on funding round data.
Can I buy Panacea stock?
Panacea shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Panacea's last funding round?
Panacea's most recent funding round was Series B on January 16, 2024.
Who are the main investors in Panacea?
Key investors in Panacea include Valar Ventures.
Will Panacea IPO soon?
No public IPO plans have been announced for Panacea.
How can I track Panacea secondary market activity?
Caplight tracks bids, offers, and trades in Panacea's shares on secondary markets.